Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angiostrongylus cantonensis | 27 | 2025 | 36 | 14.270 |
Why?
|
| Strongylida Infections | 20 | 2025 | 29 | 10.910 |
Why?
|
| Gastropoda | 8 | 2025 | 16 | 4.520 |
Why?
|
| Anthelmintics | 5 | 2022 | 23 | 3.480 |
Why?
|
| Hawaii | 21 | 2025 | 2011 | 1.620 |
Why?
|
| Rodent Diseases | 2 | 2025 | 13 | 1.580 |
Why?
|
| Rats | 14 | 2025 | 3735 | 1.560 |
Why?
|
| Animals | 38 | 2025 | 16992 | 1.460 |
Why?
|
| Plasmodium | 5 | 2014 | 16 | 1.240 |
Why?
|
| Passeriformes | 4 | 2014 | 41 | 1.160 |
Why?
|
| Bird Diseases | 3 | 2013 | 8 | 1.060 |
Why?
|
| DNA, Helminth | 3 | 2024 | 6 | 0.990 |
Why?
|
| Larva | 6 | 2024 | 133 | 0.900 |
Why?
|
| Malaria, Avian | 3 | 2014 | 4 | 0.890 |
Why?
|
| Vaccines | 1 | 2025 | 65 | 0.860 |
Why?
|
| Cat Diseases | 1 | 2024 | 27 | 0.850 |
Why?
|
| Meningoencephalitis | 2 | 2020 | 14 | 0.820 |
Why?
|
| Songbirds | 3 | 2016 | 54 | 0.810 |
Why?
|
| Snails | 2 | 2021 | 32 | 0.800 |
Why?
|
| Antimitotic Agents | 1 | 2022 | 2 | 0.760 |
Why?
|
| Genes, MHC Class II | 2 | 2016 | 21 | 0.700 |
Why?
|
| Geese | 2 | 2013 | 4 | 0.680 |
Why?
|
| West Nile Virus Vaccines | 2 | 2013 | 5 | 0.680 |
Why?
|
| Selection, Genetic | 2 | 2016 | 75 | 0.680 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 51 | 0.650 |
Why?
|
| Zoonoses | 1 | 2020 | 21 | 0.630 |
Why?
|
| West Nile Fever | 2 | 2013 | 68 | 0.630 |
Why?
|
| Antigens, Helminth | 1 | 2020 | 34 | 0.620 |
Why?
|
| Parasitology | 1 | 2019 | 2 | 0.620 |
Why?
|
| Propidium | 1 | 2019 | 20 | 0.620 |
Why?
|
| Filtration | 1 | 2019 | 17 | 0.610 |
Why?
|
| Biological Assay | 1 | 2019 | 63 | 0.600 |
Why?
|
| Genetic Variation | 2 | 2016 | 430 | 0.570 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 455 | 0.570 |
Why?
|
| Schools | 1 | 2020 | 283 | 0.560 |
Why?
|
| Albendazole | 3 | 2022 | 8 | 0.560 |
Why?
|
| Water | 1 | 2019 | 316 | 0.500 |
Why?
|
| Parasitemia | 2 | 2015 | 13 | 0.500 |
Why?
|
| Public Health | 1 | 2020 | 424 | 0.480 |
Why?
|
| Poxviridae Infections | 2 | 2012 | 3 | 0.460 |
Why?
|
| Animal Diseases | 1 | 2015 | 4 | 0.460 |
Why?
|
| Protozoan Proteins | 3 | 2012 | 191 | 0.440 |
Why?
|
| Pilot Projects | 3 | 2023 | 760 | 0.410 |
Why?
|
| Prevalence | 4 | 2025 | 1612 | 0.410 |
Why?
|
| Pest Control | 1 | 2013 | 4 | 0.400 |
Why?
|
| Avipoxvirus | 2 | 2010 | 2 | 0.400 |
Why?
|
| X-Rays | 2 | 2024 | 19 | 0.390 |
Why?
|
| Canarypox virus | 1 | 2012 | 4 | 0.390 |
Why?
|
| Antibodies, Viral | 2 | 2013 | 306 | 0.390 |
Why?
|
| Viral Vaccines | 1 | 2012 | 37 | 0.380 |
Why?
|
| Reproduction | 2 | 2024 | 94 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 3 | 2010 | 515 | 0.370 |
Why?
|
| Malaria | 1 | 2012 | 90 | 0.350 |
Why?
|
| Taq Polymerase | 1 | 2010 | 8 | 0.330 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 863 | 0.320 |
Why?
|
| Phylogeny | 3 | 2016 | 769 | 0.320 |
Why?
|
| Humans | 12 | 2025 | 43102 | 0.320 |
Why?
|
| Sensitivity and Specificity | 3 | 2024 | 611 | 0.310 |
Why?
|
| Female | 9 | 2025 | 24698 | 0.300 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.290 |
Why?
|
| DNA, Viral | 1 | 2010 | 311 | 0.290 |
Why?
|
| DNA, Protozoan | 2 | 2012 | 26 | 0.280 |
Why?
|
| Lung | 2 | 2025 | 492 | 0.270 |
Why?
|
| Alleles | 1 | 2008 | 352 | 0.260 |
Why?
|
| Birds | 1 | 2008 | 96 | 0.260 |
Why?
|
| Disease Vectors | 2 | 2019 | 11 | 0.250 |
Why?
|
| Host-Parasite Interactions | 2 | 2020 | 79 | 0.250 |
Why?
|
| Male | 6 | 2025 | 23409 | 0.240 |
Why?
|
| Antibodies, Helminth | 1 | 2025 | 24 | 0.230 |
Why?
|
| Cats | 1 | 2024 | 82 | 0.210 |
Why?
|
| Dog Diseases | 1 | 2024 | 49 | 0.210 |
Why?
|
| Dogs | 1 | 2024 | 204 | 0.200 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 74 | 0.200 |
Why?
|
| Formazans | 1 | 2022 | 5 | 0.190 |
Why?
|
| Vaccination | 1 | 2025 | 355 | 0.190 |
Why?
|
| Antinematodal Agents | 1 | 2022 | 5 | 0.190 |
Why?
|
| Glycoproteins | 1 | 2023 | 125 | 0.190 |
Why?
|
| Pyrantel Pamoate | 1 | 2022 | 1 | 0.190 |
Why?
|
| Benzimidazoles | 1 | 2022 | 43 | 0.180 |
Why?
|
| Angiostrongylus | 1 | 2021 | 1 | 0.180 |
Why?
|
| Tubulin | 1 | 2022 | 96 | 0.180 |
Why?
|
| Meningitis | 1 | 2021 | 10 | 0.180 |
Why?
|
| Species Specificity | 1 | 2020 | 286 | 0.160 |
Why?
|
| West Nile virus | 2 | 2013 | 78 | 0.150 |
Why?
|
| Micropore Filters | 1 | 2019 | 2 | 0.150 |
Why?
|
| Rain | 1 | 2019 | 10 | 0.150 |
Why?
|
| Anura | 1 | 2019 | 34 | 0.150 |
Why?
|
| Rats, Wistar | 1 | 2019 | 283 | 0.140 |
Why?
|
| Life Cycle Stages | 1 | 2017 | 29 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2018 | 55 | 0.140 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 32 | 0.140 |
Why?
|
| Chiroptera | 1 | 2018 | 25 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 1081 | 0.130 |
Why?
|
| Geography | 1 | 2017 | 110 | 0.130 |
Why?
|
| Treatment Outcome | 1 | 2022 | 1604 | 0.130 |
Why?
|
| Animals, Zoo | 2 | 2018 | 14 | 0.130 |
Why?
|
| Linear Models | 1 | 2017 | 317 | 0.130 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 267 | 0.120 |
Why?
|
| Adult | 2 | 2023 | 13872 | 0.110 |
Why?
|
| Spleen | 1 | 2015 | 204 | 0.110 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.110 |
Why?
|
| Altitude | 1 | 2014 | 10 | 0.100 |
Why?
|
| Molluscacides | 1 | 2013 | 4 | 0.100 |
Why?
|
| Heart | 1 | 2015 | 184 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 1180 | 0.100 |
Why?
|
| Sanitation | 1 | 2013 | 27 | 0.100 |
Why?
|
| Viral Core Proteins | 1 | 2012 | 12 | 0.100 |
Why?
|
| Endangered Species | 1 | 2012 | 12 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2853 | 0.100 |
Why?
|
| Vaccines, Attenuated | 1 | 2012 | 75 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 83 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 113 | 0.090 |
Why?
|
| Virulence | 1 | 2012 | 246 | 0.090 |
Why?
|
| Child | 1 | 2020 | 3443 | 0.090 |
Why?
|
| Nucleotides | 1 | 2008 | 37 | 0.070 |
Why?
|
| Young Adult | 1 | 2020 | 5080 | 0.070 |
Why?
|
| Vaccines, Subunit | 1 | 2008 | 34 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2008 | 30 | 0.070 |
Why?
|
| Viremia | 1 | 2008 | 44 | 0.070 |
Why?
|
| Animals, Wild | 1 | 2008 | 24 | 0.070 |
Why?
|
| Adolescent | 1 | 2020 | 6081 | 0.070 |
Why?
|
| Haplotypes | 1 | 2008 | 197 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 458 | 0.060 |
Why?
|
| Aged | 1 | 2020 | 8214 | 0.060 |
Why?
|
| Genotype | 1 | 2008 | 800 | 0.060 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2004 | 12 | 0.050 |
Why?
|
| Codon | 1 | 2004 | 39 | 0.050 |
Why?
|
| Gene Library | 1 | 2004 | 62 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 734 | 0.050 |
Why?
|
| Middle Aged | 1 | 2020 | 12222 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 294 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2004 | 207 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 191 | 0.050 |
Why?
|
| Base Sequence | 1 | 2004 | 983 | 0.050 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2002 | 10 | 0.050 |
Why?
|
| Horses | 1 | 2021 | 28 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2002 | 82 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1542 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2020 | 50 | 0.040 |
Why?
|
| Laboratories | 1 | 2020 | 40 | 0.040 |
Why?
|
| Demography | 1 | 2020 | 195 | 0.040 |
Why?
|
| Autopsy | 1 | 2018 | 48 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 238 | 0.030 |
Why?
|